FORMULATIONS STABLES D'ANTICORPS ANTI-CTLA4 SEULS ET EN COMBINAISON AVEC DES ANTICORPS ANTI-RECEPTEUR DE MORT PROGRAMMEE 1 (PD-1) ET LEURS PROCEDES D'UTILISATION

• 收藏
• 分享

专利权人:

MERCK SHARP & DOHME CORP.

发明人:

CHEUNG, JASON K.,DE, ARNAB,NARASIMHAN, CHAKRAVARTHY NACHU,SHARMA, MANOJ K.,YANG, XIAOYU,BURLAGE, RUBI,BHATTACHARYA, SOUMENDU

申请号：

CA3060695

公开号：

CA3060695A1

申请日:

2018.05.01

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The invention relates to stable formulations comprising antibodies or antigen binding fragments thereof that bind to cytotoxic T lymphocyte associated antigen 4 (CTLA4), optionally further containing an anti-human programmed death receptor 1 (PD-1) antibody or antigen binding fragment thereof. Also provided are methods of treating various cancers and chronic infections with the formulations of the invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/